intralesional

Type: Keyphrase
Name: intralesional
First reported Sep 08 2014 - Updated Sep 08 2014 - 1 reports

Amgen applies for EU approval of new melanoma drug

:08 in Pharmaceutical Company Product News Amgen has applied for European Medicines Agency approval of an investigational oncolytic immunotherapy for the treatment of regionally or distantly metastatic melanoma. A marketing authorisation application has ... [Published Zenopa - Sep 08 2014]
First reported Sep 05 2014 - Updated Sep 05 2014 - 1 reports

Amgen submits MAA to EMA for treatment of melanoma

(MarketLine via COMTEX News Network) -- Amgen Inc., a biotechnology company, has submitted a marketing authorization application, or MAA, to the European Medicines Agency, or EMA, via the centralized procedure for talimogene laherparepvec seeking approval ... [Published PredictWallStreet - Sep 05 2014]
First reported Sep 02 2014 - Updated Sep 03 2014 - 1 reports

Amgen submits MAA for cancer immunotherapeutic

News EditorAmgen (NASDAQ:AMGN) submits a Marketing Authorization Application to the European Medicines Agency (EMA) for talimogene laherparepvec (TL) for the treatment of adult patients with melanoma that is regionally or distantly metastatic. TL is an ... [Published Seeking Alpha - Sep 02 2014]
First reported Sep 01 2014 - Updated Sep 01 2014 - 1 reports

Surgery remains ‘gold standard’ for basal cell carcinoma

Surgery remains the ideal treatment for patients with basal cell carcinoma, according to results of an evidence review.Researchers with Columbia University Medical Center’s department of dermatology searched four databases — PubMed, Ovid MEDLINE, Cochrane ... [Published Orthopedics Today - Sep 01 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

Cerebrospinal fluid pleocytosis in multiple sclerosis patients with lesions showing reduced diffusion

In multiple sclerosis (MS) occasionally acute lesions show a reduced apparent diffusion coefficient (ADC) on magnetic resonance imaging (MRI); however, the underlying mechanism of this phenomenon is not known. We compared cerebrospinal fluid (CSF) findings ... [Published Multiple Sclerosis Journal current issue - Aug 26 2014]
First reported Aug 25 2014 - Updated Aug 25 2014 - 1 reports

Intralesional triamcinolone alone and in combination with 5-fluorouracil for the treatment of Keloid and Hypertrophic scars

AbstractObjective: To compare the use of intralesional triamcinolone acetonide and its combination with 5 flourouracil in the treatment of keloid and hypertrophic scars in terms of reduction in initial height of the scar.Methods: The randomised controlled ... [Published JPMA - Aug 25 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

Drug restores hair in patients with alopecia areata

Source: Dr P Marazzi / Science Photo LibraryIn the open-label clinical trial of 12 patients with more than 30% alopecia-related hair loss, six have so far responded favourably to treatmentScientists have shown how hair growth is restored when T cells ... [Published Pharmaceutical Journal - Aug 21 2014]
First reported Aug 18 2014 - Updated Aug 18 2014 - 1 reports

Intralesional Mycobacterium W Vaccine for Anogenital Warts

Reuters Health InformationBy Will Boggs MDAugust 18, 2014NEW YORK (Reuters Health) - Intralesional Mycobacterium w vaccine appears to be as effective as imiquimod cream for treating anogenital warts, researchers from India report.The Mycobacterium w (Mw) ... [Published General Medicine eJournal - Aug 18 2014]
First reported Aug 13 2014 - Updated Aug 13 2014 - 1 reports

Intralesional Mycobacterium w vaccine cleared HPV, anogenital warts

Intralesional injection of the Mycobacterium w vaccine appears to be equivalent to imiquimod 5% in yielding clinical and virological clearance of the HPV-6 in patients with anogenital warts,, according to recent findings published in JAMA Dermatology ... [Published Orthopedics Today - Aug 13 2014]
First reported Aug 12 2014 - Updated Aug 12 2014 - 1 reports

8-year-old girl with annular, pink plaques on the feet

An 8-year-old girl presents to your office with a rash unresponsive to therapy. She first noticed pink papules appearing on the feet 10 months ago. They gradually enlarged and developed central clearing. She denies pruritus, pain and scaling. She has ... [Published Orthopedics Today - Aug 12 2014]

Quotes

...Dr Sean Harper, executive vice-president of research and development at Amgen, said: "The submission of the marketing authorisation application in Europe for talimogene laherparepvec brings us a step closer to helping address an unmet medical need for patients with metastatic melanoma."
...helping address an unmet medical need for patients with metastatic melanoma," said Sean E Harper, M D , executive vice president of R&D at Amgen. "This regulatory milestone, on the heels of our Biologics License Application submission to the US FDA, represents an important step for our pipeline and we look forward to working with the European Medicines Agency as it conducts its review of talimogene laherparepvec."
"It is important when treating HPV-related disease to temper the expectation of the patient," Dr. Fathi said. "Warts can be extremely stubborn and not one therapy stands out above the rest. A discussion of the patient's goals, what therapy suits their lifestyle, and what side effects of therapy are acceptable for them is of clinical importance."

More Content

All (14) | News (13) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Amgen applies for EU approval of new melanoma drug [Published Zenopa - Sep 08 2014]
Amgen submits MAA to EMA for treatment of melanoma [Published PredictWallStreet - Sep 05 2014]
Amgen submits talimogene laherparepvec's MAA fo... [Published Individual.com - Sep 03 2014]
Amgen files for EU approval of talimogene laher... [Published Pharma Letter - Sep 03 2014]
Amgen submits MAA for cancer immunotherapeutic [Published Seeking Alpha - Sep 02 2014]
Amgen Submits MAA In Europe For Talimogene Lahe... [Published RTTNews.com - Sep 02 2014]
Surgery remains ‘gold standard’ for basal cell ... [Published Orthopedics Today - Sep 01 2014]
Cerebrospinal fluid pleocytosis in multiple scl... [Published Multiple Sclerosis Journal current issue - Aug 26 2014]
Intralesional triamcinolone alone and in combin... [Published JPMA - Aug 25 2014]
Drug restores hair in patients with alopecia ar... [Published Pharmaceutical Journal - Aug 21 2014]
Intralesional Mycobacterium W Vaccine for Anoge... [Published General Medicine eJournal - Aug 18 2014]
Intralesional Mycobacterium w vaccine cleared H... [Published Orthopedics Today - Aug 13 2014]
8-year-old girl with annular, pink plaques on t... [Published Orthopedics Today - Aug 12 2014]
Treatment of hepatitis C virus with telaprevir ... [Published PharmCast - Mar 19 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Cerebrospinal fluid pleocytosis in multiple scl... [Published Multiple Sclerosis Journal current issue - Aug 26 2014]
In multiple sclerosis (MS) occasionally acute lesions show a reduced apparent diffusion coefficient (ADC) on magnetic resonance imaging (MRI); however, the underlying mechanism of this phenomenon is not known. We compared cerebrospinal fluid (CSF) findings ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.